Extracorporeal Shockwave Therapy in Long-term Functional Outcomes of Shoulder Adhesive Capsulitis
Effects Of Extracorporeal Shockwave Therapy in Long-term Functional Outcomes of Shoulder Adhesive Capsulitis
1 other identifier
interventional
26
1 country
1
Brief Summary
Adhesive capsulitis refers to the occurrence of pain and a gradual decline in the range of motion (ROM) due to slow increases in synovial hypertrophy and the adhesion between the synovial membrane and articular surface. It leads to the loss of flexibility and difficulties with the activities of daily living (ADLs) due to chronic inflammation accompanied by intra-articular fibrosis. The real cause of this syndrome is unknown but there are some predisposing factors involved such as synovial cell hyperplasia, fibrosis of the capsule due to cytokines or other inflammatory factors. In the current study investigator will compare the effects of Extracorporeal Shockwave Therapy (ESWT) along with conventional therapy to treat the adhesive capsulitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2020
CompletedFirst Submitted
Initial submission to the registry
September 25, 2020
CompletedFirst Posted
Study publicly available on registry
October 8, 2020
CompletedOctober 8, 2020
October 1, 2020
8 months
September 25, 2020
October 6, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Constant Shoulder Score (CSS)
The functional outcome of shoulder. Grading the Constant Shoulder Score (Difference between normal and Abnormal Side) \>30 Poor 21-30 Fair 11-20 Good \<11 Excellent
8 months
Range of motion
Oxford Shoulder Score (OSS), increasing score shows improvement, decrease in scores shows deterioration.
8 months
Secondary Outcomes (1)
NPRS-numeric pain rating scale
8 months
Study Arms (2)
Shockwavetherapy Group/Experimental group
EXPERIMENTALESWT along with conventional therapy ESWT + hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder
Conventional Group
ACTIVE COMPARATORConventional therapy hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder
Interventions
ESWT along with conventional therapy ESWT + hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder
hot pack(10min), ultrasound (5min), mobilizations, stretching, pendulum exercises, isometrics of shoulder
Eligibility Criteria
You may qualify if:
- Relapsed or episode of pain score ≥5 at assessment with a past history of pain for at least 2 months.
- ROM restriction (\>75% ROM loss in ≥2 directions including abduction, flexion and external rotation)
- No treatment other than analgesics with unresponsive ROM restriction for the past 2months.
- Unwilling or waiting and did not undergo joint injection.
You may not qualify if:
- bilateral shoulder involvement
- History of previous surgery on the shoulder
- Shoulder fracture
- Cancer
- Glenohumeral or Acromioclavicular arthritis
- Inflammatory disorders
- Bleeding disorders
- Diabetes mellitus
- Presence of severe osteoporosis
- Pulmonary diseases
- Any neuromuscular disorders
- Pregnancy
- Implanted pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riphah IU
Lahore, 54000, Pakistan
Related Publications (7)
Calis M, Demir H, Ulker S, Kirnap M, Duygulu F, Calis HT. Is intraarticular sodium hyaluronate injection an alternative treatment in patients with adhesive capsulitis? Rheumatol Int. 2006 Apr;26(6):536-40. doi: 10.1007/s00296-005-0022-2. Epub 2005 Aug 10.
PMID: 16091920BACKGROUNDHussein AZ, Donatelli RA. The efficacy of radial extracorporeal shockwave therapy in shoulder adhesive capsulitis: a prospective, randomised, double-blind, placebo-controlled, clinical study. European Journal of Physiotherapy. 2015;18(1):63-76.
BACKGROUNDMassoud SN, Pearse EO, Levy O, Copeland SA. Operative management of the frozen shoulder in patients with diabetes. J Shoulder Elbow Surg. 2002 Nov-Dec;11(6):609-13. doi: 10.1067/mse.2002.127301.
PMID: 12469088BACKGROUNDWohlgethan JR. Frozen shoulder in hyperthyroidism. Arthritis Rheum. 1987 Aug;30(8):936-9. doi: 10.1002/art.1780300815.
PMID: 3498494BACKGROUNDLee S, Lee S, Jeong M, Oh H, Lee K. The effects of extracorporeal shock wave therapy on pain and range of motion in patients with adhesive capsulitis. J Phys Ther Sci. 2017 Nov;29(11):1907-1909. doi: 10.1589/jpts.29.1907. Epub 2017 Nov 24.
PMID: 29200621BACKGROUNDSantoboni F, Balducci S, D'Errico V, Haxhi J, Vetrano M, Piccinini G, Ferretti A, Pugliese G, Vulpiani MC. Extracorporeal Shockwave Therapy Improves Functional Outcomes of Adhesive Capsulitis of the Shoulder in Patients With Diabetes. Diabetes Care. 2017 Feb;40(2):e12-e13. doi: 10.2337/dc16-2063. Epub 2016 Nov 29. No abstract available.
PMID: 27899492BACKGROUNDChen CY, Hu CC, Weng PW, Huang YM, Chiang CJ, Chen CH, Tsuang YH, Yang RS, Sun JS, Cheng CK. Extracorporeal shockwave therapy improves short-term functional outcomes of shoulder adhesive capsulitis. J Shoulder Elbow Surg. 2014 Dec;23(12):1843-1851. doi: 10.1016/j.jse.2014.08.010.
PMID: 25441567BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maryam Shabbir, M.Phil
Riphah International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 25, 2020
First Posted
October 8, 2020
Study Start
October 15, 2019
Primary Completion
June 20, 2020
Study Completion
June 28, 2020
Last Updated
October 8, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share